Â¥
4.14
May 27
New Key Statistics Module, Z-Score and F-Score
SZSE:002424 Key Ratios
Market Cap ¥ M | 5,842.37 |
Enterprise Value ¥ M | 7,694.61 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 1.68 |
Price/Sales | 1.24 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 4,504.00 |
EPS (TTM) ¥ | -0.33 |
Beneish M-Score | -2.74 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -254.90 |
EV-to-EBIT | -16.44 |
EV-to-EBITDA | -16.44 |
PEG | -- |
Shares Outstanding M | 1,411.20 |
Net Margin (%) | -10.11 |
Operating Margin % | -7.19 |
Pre-tax Margin (%) | -12.30 |
Quick Ratio | 0.80 |
Current Ratio | 1.10 |
ROA % (ttm) | -6.22 |
ROE % (ttm) | -11.96 |
ROIC % (ttm) | -4.84 |
Dividend Yield % | -- |
Altman Z-Score | 1.61 |
SZSE:002424 Number of Guru Trades
SZSE:002424 Volume of Guru Trades
Gurus Latest Trades with SZSE:002424
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002424 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Guizhou Bailing Group Pharmaceutical Co Ltd Insider Transactions
No Available Data